The store will not work correctly when cookies are disabled.
1-(4-methoxyphenethyl)-4-phenethylpiperazine dihydrochloride
ID: ALA4532351
PubChem CID: 155546919
Max Phase: Preclinical
Molecular Formula: C21H30Cl2N2O
Molecular Weight: 324.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CCN2CCN(CCc3ccccc3)CC2)cc1.Cl.Cl
Standard InChI: InChI=1S/C21H28N2O.2ClH/c1-24-21-9-7-20(8-10-21)12-14-23-17-15-22(16-18-23)13-11-19-5-3-2-4-6-19;;/h2-10H,11-18H2,1H3;2*1H
Standard InChI Key: ZTDCYMXDGBFPFD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 26 0 0 0 0 0 0 0 0999 V2000
12.7810 -7.0157 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.2311 -8.5537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8225 -9.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0012 -9.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5926 -8.5537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0012 -7.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8225 -7.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7754 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3668 -7.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5496 -7.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1410 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3238 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9152 -7.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3238 -7.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1410 -7.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0483 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4569 -9.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2741 -9.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6827 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4999 -8.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9085 -9.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4999 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6827 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7257 -9.2628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1343 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4612 -6.8420 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
5 8 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
24 25 1 0
21 24 1 0
2 16 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.47 | Molecular Weight (Monoisotopic): 324.2202 | AlogP: 3.10 | #Rotatable Bonds: 7 |
Polar Surface Area: 15.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.30 | CX LogP: 3.91 | CX LogD: 2.96 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.78 | Np Likeness Score: -0.61 |
References
1. Nickell JR, Culver JP, Janganati V, Zheng G, Dwoskin LP, Crooks PA.. (2016) Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2., 26 (18): [PMID:27524311] [10.1016/j.bmcl.2016.08.001] |